Foxo technologies inc. announces reverse stock split

Minneapolis--(business wire)--foxo technologies inc. (nyse american: foxo) (“foxo” or the “company”), a leader in the field of commercializing epigenetic biomarker technology, today announced that its board of directors has approved a 1-for-10 reverse stock split of the company's class a common stock, par value $0.0001 (the “common stock”). the reverse stock split will become effective at 4:01pm et on november 6, 2023. the common stock is expected to begin trading on a split-adjusted basis on t.
FOXO Ratings Summary
FOXO Quant Ranking